glp 1 and graves disease GLP-1 receptor agonists next-generation metabolic hormone therapies in chronic kidney glp 1 and graves disease

An expert weighs in on why hidden side effects, such as Ozempic chills, may occur

Or is the media just obsessed with creating hyperbole around weight loss medications and making women feel bad about their bodies

doi: 10.3390/ijms24032428 [DOI] [PMC free article] [PubMed] [Google Scholar] 175.You HL, Liu TT, Weng SW, et al

Some research suggests these medications may cause mild vasodilation and potentially reduce systemic vascular resistance, which could trigger a compensatory increase in heart rate to maintain cardiac output and blood pressure

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial